Multi-center clinical trial of radiofrenquency ablation in early stage non-small cell lung cancer

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNRC-10001083

Enrollment

Unknown

Registered

2010-09-11

Start date

2007-11-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

A:radiofrequency ablation

Eligibility

Sex/Gender

All

Age

19 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. High risk patients; 2. Elderly patients; 3. Patient refusal surgery; 4. Lesion located at least 1 cm away from major vessels or airways.

Exclusion criteria

Exclusion criteria: 1. Performance status>2(ECOG); 2. Medical comorbidities; 3. Uncorrectable coagulopathy with an international normalized ratio greater than 1.5 and a platelet count of less than 106/mm3.

Design outcomes

Primary

Measure	Time frame
Survival rate;	—

Countries

China

Contacts

Public ContactBaodong Liu

dr.liubaodong@yahoo.com.cn+86 010 83198646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026